FDA Warning Letter — Roslindale Market
The FDA took a Warning Letter action against Roslindale Market on May 4, 2017 (Boston, MA). The action was issued by CTP and concerns tobacco products.
Action Details
- Facility
- Roslindale Market
- Date
- May 4, 2017
- Fiscal Year
- 2017
- Product Type
- Tobacco
- Center
- CTP
- Location
- Boston, MA (United States)